Abnormal activation of NF‐κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid‐derived suppressor cells to shape the immunosuppressive tumor immune microenvironment
Thoracic Cancer · 2023-07 · 14 (19) · 1843-1856
DOI: 10.1111/1759-7714.14929 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 23.05.2023. Verfasst von Chao Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of M…. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Myeloid-Derived Suppressor Cells. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Osimertinib is the first‐line treatment for patients with epidermal growth factor receptor ( EGFR ) mutations, but the treatment options after drug resistance are limited. Previous studies have suggested that EGFR is in an immunosuppressive tumor immune microenvironment (TIME). However, the evolution of TIME after osimertinib resistance and whether this resistance can be overcome by targeting TIME needs to be further investigated.
Methods
The remodeling process and mechanism of TIME during the treatment with osimertinib were studied.
Results
The proportion of EGFR L858R + T790M mutant tumor immune infiltrating cells was extremely low. Osimertinib treatment transiently triggered inflammatory cells, but several immunosuppressive cells infiltrated after drug resistance and formed a myeloid‐derived suppressor cell (MDSC)‐enriched TIME. The programmed cell death protein‐1 monoclonal antibody was not able to reverse the MDSC‐enriched TIME. Further analysis revealed that the activation of nuclear factor‐kappa B ( NF‐κB ) and mitogen‐activated protein kinase (MAPK) pathways recruited a large number of MDSCs via cytokines. Finally, MDSC secreted high levels of interleukin‐10 and arginase‐1 and created an immunosuppressive TIME.
Conclusions
Thus, our findings lay the foundation for the evolution of TIME in osimertinib treatment, establish the mechanism of immunosuppressive TIME after osimertinib resistance, and propose potential solutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Guangdong Provincial People's Hospital/Guangdong Provincial Academy of Medical Sciences, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong, China.
ORCID-Profile: Kailun Fei, Jianchun Duan, Jiachen Xu, Jie Wang
Zitieren
APA
Wang, C., Fei, K., Liu, L., Duan, J., Wang, Z., Li, S., Xu, J., Zhang, X., Tian, Y., Qu, Y., Bai, H., & Wang, J. (2023). Abnormal activation of NF‐κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid‐derived suppressor cells to shape the immunosuppressive tumor immune microenvironment. Thoracic Cancer, 14(19), 1843-1856. https://doi.org/10.1111/1759-7714.14929
Vancouver
Wang C, Fei K, Liu L, Duan J, Wang Z, Li S, et al. Abnormal activation of NF‐κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid‐derived suppressor cells to shape the immunosuppressive tumor immune microenvironment. Thoracic Cancer. 2023;14(19):1843-1856. doi:10.1111/1759-7714.14929
BibTeX
@article{Wang2023,
author = {Wang, Chao and Fei, Kailun and Liu, Lihui and Duan, Jianchun and Wang, Zhijie and Li, Sini and Xu, Jiachen and Zhang, Xue and Tian, Yanhua and Qu, Yan and Bai, Hua and Wang, Jie},
title = {Abnormal activation of NF‐κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid‐derived suppressor cells to shape the immunosuppressive tumor immune microenvironment},
journal = {Thoracic Cancer},
year = {2023},
volume = {14},
number = {19},
pages = {1843--1856},
doi = {10.1111/1759-7714.14929}
}
EUVIMED